STOCK TITAN

Apellis Pharmaceuticals, Inc. (APLS) Net Income by Year

APLS

Apellis Pharmaceuticals, Inc. reported $22.4M in net income in fiscal year 2025. This represents an increase of 111.3% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $133.3M in net income. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Apellis Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income $22.4M
YoY +111.3%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

APLS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income$133.3M$22.4M+111.3%-$197.9M+62.6%-$528.6M+18.9%-$652.2M+12.6%-$746.4M-116.4%-$344.9M-13.2%-$304.7M-139.0%-$127.5M-150.0%-$51.0M-88.0%-$27.1M+41.7%-$46.5M

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

APLS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Net Income$18.7M+120.2%-$59.0M-62.2%$215.7M+475.5%-$42.2M-11.9%-$92.2M-38.8%-$36.4M+59.0%-$57.4M+59.0%-$37.7M+69.1%-$66.4M+62.6%-$88.6M+46.6%-$140.2M+26.7%-$122.0M+21.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Apellis Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Apellis Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Apellis Pharmaceuticals, Inc. reported $22.4M in net income in fiscal year 2025.

How fast is Apellis Pharmaceuticals, Inc.'s net income growing?

Apellis Pharmaceuticals, Inc. (APLS) net income rose by 111.3% year over year, from -$197.9M to $22.4M in fiscal year 2025.

What is Apellis Pharmaceuticals, Inc.'s net income over the last twelve months?

Apellis Pharmaceuticals, Inc. (APLS) reported $133.3M in net income over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, Apellis Pharmaceuticals, Inc. (APLS) net income went from -$46.5M in fiscal year 2015 to $22.4M in fiscal year 2025.

Apellis Pharmaceuticals, Inc. (APLS) reported $18.7M in net income in Q1 2026. This represents an increase of 120.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Apellis Pharmaceuticals, Inc. (APLS) reported on that line in every period on record.